Africure Pharmaceuticals Ltd (AFRP.mu) Q32023 Interim Report
Africure Pharmaceuticals Ltd (AFRP.mu) listed on the Stock Exchange of Mauritius under the Pharmaceuticals sector has released it’s 2023 interim results for the third quarter.
For more information about Africure Pharmaceuticals Ltd (AFRP.mu) reports, abridged reports, interim earnings results and earnings presentations visit the Africure Pharmaceuticals Ltd (AFRP.mu) company page on AfricanFinancials.
Africure Pharmaceuticals Ltd 2023 interim results for the third quarter
Company Profile
Africure Pharmaceuticals Ltd is a manufacturer and distributor of high quality essential medication in Africa. It was incorporated on 17 March 2017 and holds a Global Business Licence issued by the Financial Services Commission. The principal activity of the Company is investment holding, trading & procurement of pharmaceutical products. Africure Pharmaceuticals Ltd is listed on the Stock Exchange of Mauritius
Recent Documents & News
-
Interim Reports
Africure Pharmaceuticals Ltd (AFRP.mu) Q12023 Interim Report – November 30, 2022 -
Interim Reports
Africure Pharmaceuticals Ltd (AFRP.mu) Q32022 Interim Report – November 30, 2022 -
Interim Reports
Africure Pharmaceuticals Ltd (AFRP.mu) Q12022 Interim Report – November 30, 2022 -
Interim Reports
Africure Pharmaceuticals Ltd (AFRP.mu) HY2023 Interim Report – November 30, 2022 -
Abridged Reports
Africure Pharmaceuticals Ltd (AFRP.mu) 2022 Abridged Report – November 30, 2022
